Actively Recruiting
Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2025-04-11
15
Participants Needed
2
Research Sites
102 weeks
Total Duration
On this page
Sponsors
I
Insel Gruppe AG, University Hospital Bern
Lead Sponsor
E
ETH Zurich
Collaborating Sponsor
AI-Summary
What this Trial Is About
This pilot study aims to evaluate the feasibility and acceptability of nocturnal translational vestibular stimulations (VS) applied by a rocking bed (Somnomat Casa) for two months in patients with Parkinson's Disease.
CONDITIONS
Official Title
Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Diagnosis of Parkinson's Disease according to MDS clinical criteria
- Reduced sleep quality with Pittsburgh Sleep Quality Index score > 5
- Stable antiparkinsonian, antidepressant, and sleep medications for six weeks before and during intervention
- No bilateral deep brain stimulation treatment
- Fluent in German
You will not qualify if you...
- Other brain diseases besides Parkinson's Disease (e.g., atypical Parkinsonism, Alzheimer's, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy)
- Dementia with MOCA score below 24/30
- Weight over 150 kg
- Depression with acute suicidal thoughts
- Major uncontrolled psychiatric illness like acute psychosis
- Poor general health (e.g., uncontrolled diabetes, uncontrolled hypertension, cancer therapy)
- Inability to follow study procedures due to language, psychological disorders, or dementia
- Participation in another interventional trial within 30 days before or during this study
- Pittsburgh Sleep Quality Index score 5 or lower
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Insel Gruppe AG, University Hospital Bern
Bern, Switzerland, 3010
Actively Recruiting
2
ETH Zurich, Sensory-Motor Systems Lab, IRIS
Zurich, Switzerland, 8092
Not Yet Recruiting
Research Team
L
Lenard Lachenmayer, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here